FR08C0028I1 - - Google Patents

Info

Publication number
FR08C0028I1
FR08C0028I1 FR08C0028C FR08C0028I1 FR 08C0028 I1 FR08C0028 I1 FR 08C0028I1 FR 08C0028 C FR08C0028 C FR 08C0028C FR 08C0028 I1 FR08C0028 I1 FR 08C0028I1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26305774&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR08C0028(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB9420425A external-priority patent/GB9420425D0/en
Priority claimed from GBGB9508745.8A external-priority patent/GB9508745D0/en
Application filed filed Critical
Publication of FR08C0028I1 publication Critical patent/FR08C0028I1/fr
Application granted granted Critical
Publication of FR08C0028I2 publication Critical patent/FR08C0028I2/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR08C0028C 1994-10-07 2008-06-27 Active FR08C0028I2 (enrdf_load_stackoverflow)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9420425A GB9420425D0 (en) 1994-10-07 1994-10-07 New compound
GBGB9508745.8A GB9508745D0 (en) 1995-04-28 1995-04-28 New compound
PCT/JP1995/001983 WO1996011210A1 (en) 1994-10-07 1995-09-29 Cyclic hexapeptides having antibiotic activity

Publications (2)

Publication Number Publication Date
FR08C0028I1 true FR08C0028I1 (enrdf_load_stackoverflow) 2008-08-15
FR08C0028I2 FR08C0028I2 (enrdf_load_stackoverflow) 2009-11-20

Family

ID=26305774

Family Applications (1)

Application Number Title Priority Date Filing Date
FR08C0028C Active FR08C0028I2 (enrdf_load_stackoverflow) 1994-10-07 2008-06-27

Country Status (26)

Country Link
US (2) US6107458A (enrdf_load_stackoverflow)
EP (1) EP0788511B1 (enrdf_load_stackoverflow)
JP (2) JP2897427B2 (enrdf_load_stackoverflow)
KR (1) KR100353303B1 (enrdf_load_stackoverflow)
CN (1) CN1203089C (enrdf_load_stackoverflow)
AR (1) AR041770A1 (enrdf_load_stackoverflow)
AT (1) ATE229541T1 (enrdf_load_stackoverflow)
AU (1) AU696949B2 (enrdf_load_stackoverflow)
BR (2) BRPI9504791B8 (enrdf_load_stackoverflow)
CA (1) CA2202058C (enrdf_load_stackoverflow)
DE (2) DE69529172T2 (enrdf_load_stackoverflow)
DK (1) DK0788511T3 (enrdf_load_stackoverflow)
ES (1) ES2187575T3 (enrdf_load_stackoverflow)
FI (1) FI119988B (enrdf_load_stackoverflow)
FR (1) FR08C0028I2 (enrdf_load_stackoverflow)
HU (1) HU228151B1 (enrdf_load_stackoverflow)
IL (1) IL115484A (enrdf_load_stackoverflow)
LU (1) LU91452I2 (enrdf_load_stackoverflow)
MX (1) MX9702531A (enrdf_load_stackoverflow)
NL (1) NL300352I2 (enrdf_load_stackoverflow)
NO (2) NO328483B1 (enrdf_load_stackoverflow)
OA (1) OA10475A (enrdf_load_stackoverflow)
PT (1) PT788511E (enrdf_load_stackoverflow)
RU (1) RU2165423C2 (enrdf_load_stackoverflow)
TR (1) TR199501229A2 (enrdf_load_stackoverflow)
WO (1) WO1996011210A1 (enrdf_load_stackoverflow)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5696084A (en) * 1996-08-16 1997-12-09 Abbott Laboratories Amino-lipopetide antifungal agents
AUPO371596A0 (en) * 1996-11-19 1996-12-12 Fujisawa Pharmaceutical Co., Ltd. New compound
AUPO381496A0 (en) * 1996-11-25 1996-12-19 Fujisawa Pharmaceutical Co., Ltd. New compound
EP0994101A4 (en) * 1997-06-18 2002-05-02 Fujisawa Pharmaceutical Co NEW PREPARATION PROCESS
AU756792B2 (en) * 1998-02-09 2003-01-23 Fujisawa Pharmaceutical Co., Ltd. New compound
EP1053247A1 (en) * 1998-02-09 2000-11-22 Fujisawa Pharmaceutical Co., Ltd. Antifungal cyclohexapeptides
US7084279B1 (en) * 1999-02-11 2006-08-01 Emisphere Technologies Inc. Oxadiazole compounds and compositions for delivering active agents
CA2360220C (en) * 1999-02-11 2009-09-08 Emisphere Technologies, Inc. Oxadiazole compounds and compositions for delivering active agents
AUPP999799A0 (en) * 1999-04-27 1999-05-20 Fujisawa Pharmaceutical Co., Ltd. New compound
AUPQ066399A0 (en) * 1999-05-31 1999-06-24 Fujisawa Pharmaceutical Co., Ltd. Antifungal combination use
TWI233805B (en) * 1999-07-01 2005-06-11 Fujisawa Pharmaceutical Co Stabilized pharmaceutical composition in lyophilized form as antifungal agent
CA2380176A1 (en) * 1999-07-27 2001-02-01 Aventis Pharma Deutschland Gmbh Novel cyclohexapeptide compounds, processes for their production and their use as a pharmaceutical
AUPQ462399A0 (en) * 1999-12-13 2000-01-13 Fujisawa Pharmaceutical Co., Ltd. New use
TWI250992B (en) 2000-02-21 2006-03-11 Astellas Pharma Inc Polypeptide compounds for the prophylactic and/or therapeutic treatment of infectious diseases caused by pathogenic microorganisms
ES2191516B1 (es) * 2000-07-28 2005-01-01 Consejo Superior De Investigaciones Cientificas Antibioticos antifungicos de naturaleza peptidica inhibidores de la germinacion y el crecimiento de hongos fitopatogenos.
AUPQ938700A0 (en) * 2000-08-14 2000-09-07 Fujisawa Pharmaceutical Co., Ltd. Antifungal combination use
US7867516B2 (en) 2001-01-29 2011-01-11 Shionogi & Co., Ltd. Medicinal preparation containing 5-methyl-1-phenyl-2-(1h)-pyridone as active ingredient
JP2005053782A (ja) * 2001-08-31 2005-03-03 Fujisawa Pharmaceut Co Ltd 環状リポペプチド化合物の新規結晶
KR20040088519A (ko) 2002-02-22 2004-10-16 뉴 리버 파마슈티칼스, 인크. 활성 제제 전달 시스템 및 활성 제제의 보호 및 투여 방법
WO2004014879A1 (en) * 2002-08-08 2004-02-19 Fujisawa Pharmaceutical Co., Ltd. New process
AU2003903205A0 (en) * 2003-06-23 2003-07-10 Fujisawa Pharmaceutical Co., Ltd. New compound
JP4664912B2 (ja) * 2003-07-22 2011-04-06 セラヴァンス， インコーポレーテッド グリコペプチド抗菌剤と組み合わせたエキノカンジン抗真菌剤の使用
CN1845751A (zh) * 2003-09-05 2006-10-11 默克公司 固定相和利用该固定相的纯化方法
EP1669350B1 (en) * 2003-09-22 2012-02-29 Msd K.K. Piperidine derivatives
US7476673B2 (en) * 2003-12-30 2009-01-13 Allergan, Inc. Disubstituted chalcone oximes as selective agonists of RARγ retinoid receptors
WO2005118511A2 (en) * 2004-05-20 2005-12-15 The Scripps Research Institute Compounds, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
BRPI0515482A (pt) 2004-09-20 2008-07-22 Xenon Pharmaceuticals Inc derivados heterocìclicos e seus usos como agentes terapêuticos
US8071603B2 (en) 2004-09-20 2011-12-06 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
CN101083992A (zh) 2004-09-20 2007-12-05 泽农医药公司 抑制人硬脂酰CoA去饱和酶的哒嗪衍生物
US7777036B2 (en) 2004-09-20 2010-08-17 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as therapeutic agents
CN101083994A (zh) 2004-09-20 2007-12-05 泽农医药公司 杂环衍生物及其用作硬脂酰CoA去饱和酶抑制剂的用途
EP1830837B1 (en) 2004-09-20 2013-09-04 Xenon Pharmaceuticals Inc. Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes
WO2006034338A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as mediators of stearoyl-coa desaturase
EP3067053A1 (en) * 2004-10-13 2016-09-14 PTC Therapeutics, Inc. Compounds for nonsense suppression, and methods for their use
AU2006343359A1 (en) 2005-06-03 2007-11-15 Xenon Pharmaceuticals Inc. Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
WO2007043401A1 (ja) * 2005-10-07 2007-04-19 Kissei Pharmaceutical Co., Ltd. 含窒素複素環化合物およびそれを含有する医薬組成物
CN101516387B (zh) * 2006-07-26 2014-06-04 桑多斯股份公司 卡泊芬净制剂
US8853392B2 (en) 2007-06-03 2014-10-07 Vanderbilt University Benzamide mGluR5 positive allosteric modulators and methods of making and using same
TWI546016B (zh) * 2007-08-13 2016-08-21 孟山都科技有限責任公司 控制植物寄生性線蟲的化合物及方法以及被覆有該化合物之種子
AU2008319977A1 (en) * 2007-10-29 2009-05-07 Astellas Pharma Inc. Polypeptide compound
US8034806B2 (en) 2007-11-02 2011-10-11 Vanderbilt University Bicyclic mGluR5 positive allosteric modulators and methods of making and using same
BRPI0914629A2 (pt) * 2008-06-24 2019-09-24 Irm Llc compostos e métodos para a modulação de receptores acoplados à proteína g
US9394340B2 (en) 2009-03-24 2016-07-19 Cadila Healthcare Limited Purification process for lipopeptides
BR112013023531A2 (pt) 2011-04-04 2016-12-06 Xellia Pharmaceuticals Aps processo de um único vaso para a fabricação de micafungina ou de um sal desta
CA2832145C (en) 2011-04-20 2020-10-20 Xellia Pharmaceuticals Aps Method for purification of micafungin
CN102775476B (zh) * 2011-05-12 2015-01-07 上海天伟生物制药有限公司 一种米卡芬净钠盐的制备方法
WO2012158844A1 (en) 2011-05-17 2012-11-22 Shionogi & Co., Ltd. Heterocyclic compounds
CN103917531B (zh) * 2011-09-09 2016-08-24 桑多斯股份公司 米卡芬净中间体的制备
CN102627689B (zh) * 2012-03-30 2014-08-06 上海天伟生物制药有限公司 一种环肽类化合物的水合物及其制备方法和用途
CN102627688B (zh) 2012-03-30 2014-12-31 上海天伟生物制药有限公司 一种高纯度环肽化合物及其制备方法和用途
CN102659930B (zh) 2012-03-30 2014-04-23 上海天伟生物制药有限公司 一种高纯度环肽类物质的晶体及其制备方法和用途
JP7109189B2 (ja) * 2014-05-29 2022-07-29 シャンハイ テックウェル バイオファーマシューティカル カンパニー リミテッド シクロペプチド系化合物の組成物およびその製造方法と使用
EP3150623B1 (en) * 2014-05-29 2019-04-03 Shanghai Techwell Biopharmaceutical Co., Ltd Solvate of cyclic peptide compound, preparation method for same, and uses thereof
EP3226885A4 (en) * 2014-10-07 2018-07-18 Alaparthi, Lakshmi Prasad Intermediates and processes to prepare micafungin
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
EP3485873A1 (en) 2017-11-17 2019-05-22 Cadila Healthcare Limited Stable pharmaceutical injectable compositions of micafungin
CN108752430B (zh) * 2018-05-31 2022-02-18 杭州中美华东制药有限公司 米卡芬净钠新晶型及其制备方法
WO2020013116A1 (ja) * 2018-07-10 2020-01-16 京都薬品工業株式会社 Ｐｔｐ－１ｂ阻害剤およびその用途
CN110734408A (zh) * 2019-10-22 2020-01-31 重庆康乐制药有限公司 一种米卡芬净类衍生物侧链中间体的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1574603A1 (ru) * 1988-08-11 1990-06-30 Ивановский Химико-Технологический Институт Способ получени мезо-тетраарилоктаметилпорфиринов
IE912046A1 (en) * 1990-06-18 1991-12-18 Fujisawa Pharmaceutical Co New polypeptide compound and a process for preparation¹thereof
CA2091663C (en) * 1992-03-19 2007-10-30 Frederick Joseph Burkhardt Cyclic peptide antifungal agents and process for preparation thereof

Also Published As

Publication number Publication date
WO1996011210A1 (en) 1996-04-18
MX9702531A (es) 1997-06-28
ATE229541T1 (de) 2002-12-15
CA2202058A1 (en) 1996-04-18
BR9504791A (pt) 1996-10-22
CN1168675A (zh) 1997-12-24
NO2010016I1 (no) 2010-08-16
LU91452I2 (fr) 2008-08-04
BRPI9504791B8 (pt) 2019-12-31
JPH10507174A (ja) 1998-07-14
CN1203089C (zh) 2005-05-25
KR100353303B1 (ko) 2003-01-15
AU696949B2 (en) 1998-09-24
EP0788511B1 (en) 2002-12-11
FI971397A0 (fi) 1997-04-04
AU3578095A (en) 1996-05-02
DE69529172T2 (de) 2003-04-17
DE122008000025I1 (de) 2008-08-21
HUT77736A (hu) 1998-07-28
NO2010016I2 (no) 2011-10-17
US6265536B1 (en) 2001-07-24
KR970707150A (ko) 1997-12-01
NL300352I2 (nl) 2008-11-03
FR08C0028I2 (enrdf_load_stackoverflow) 2009-11-20
JP2897427B2 (ja) 1999-05-31
AR041770A1 (es) 2005-06-01
IL115484A (en) 2000-07-16
HU228151B1 (en) 2012-12-28
ES2187575T3 (es) 2003-06-16
PT788511E (pt) 2003-04-30
US6107458A (en) 2000-08-22
DK0788511T3 (da) 2003-03-31
IL115484A0 (en) 1996-01-19
OA10475A (en) 2002-04-08
FI971397L (fi) 1997-05-27
NL300352I1 (nl) 2008-08-01
TR199501229A2 (tr) 1996-07-21
FI119988B (fi) 2009-05-29
RU2165423C2 (ru) 2001-04-20
NO971544L (no) 1997-06-04
NO328483B1 (no) 2010-03-01
BR9504791B1 (pt) 2010-10-05
NO971544D0 (no) 1997-04-04
DE69529172D1 (de) 2003-01-23
CA2202058C (en) 2007-11-06
DE122008000025I2 (de) 2011-02-17
JP3518665B2 (ja) 2004-04-12
HK1004136A1 (en) 1998-11-20
JPH10324695A (ja) 1998-12-08
EP0788511A1 (en) 1997-08-13

Similar Documents

Publication Publication Date Title
FR08C0028I2 (enrdf_load_stackoverflow)
TW275169B (enrdf_load_stackoverflow)
TW272261B (enrdf_load_stackoverflow)
TW272315B (enrdf_load_stackoverflow)
DK105996A (enrdf_load_stackoverflow)
EP0666525A3 (enrdf_load_stackoverflow)
EP0669395A3 (enrdf_load_stackoverflow)
EP0669187A3 (enrdf_load_stackoverflow)
TW280060B (enrdf_load_stackoverflow)
TW284768B (enrdf_load_stackoverflow)
EP0667387A3 (enrdf_load_stackoverflow)
EP0667627A3 (enrdf_load_stackoverflow)
FR2727188B1 (enrdf_load_stackoverflow)
TW267946B (enrdf_load_stackoverflow)
ITMI951973A0 (enrdf_load_stackoverflow)
TW274579B (enrdf_load_stackoverflow)
JP1006328S (enrdf_load_stackoverflow)
FR2725790B1 (enrdf_load_stackoverflow)
ECSDI940187S (enrdf_load_stackoverflow)
ECSMU940034U (enrdf_load_stackoverflow)
EP0662420A3 (enrdf_load_stackoverflow)
IN184176B (enrdf_load_stackoverflow)
ECSMU940030U (enrdf_load_stackoverflow)
ECSDI940193S (enrdf_load_stackoverflow)
ECSDI940191S (enrdf_load_stackoverflow)